News and Events

Clinical trial researching drug therapy for central nervous system tumors

A clinical trial led by Marta Penas-Prado, M.D., M.Sc., Senior Clinician in the Neuro-Oncology Branch, is researching drug therapy for tumors of the central nervous system.

Understanding the Risk of Second Cancers After CAR T-Cell Therapy

Two recent reports in the New England Journal of Medicine are seeking to determine if there may be a causal link between CAR T-cell treatment and second cancers. In this Q&A, Stephanie L. Goff, M.D., Senior Research Physician in the Surgery Branch, discusses the findings and what this issue may mean in general for patients and this area of research.

Clinical trial researching immunotherapy for throat cancer

A clinical trial led by Clint T. Allen, M.D., Senior Investigator in the Surgical Oncology Program, is researching combination immunotherapy for HPV-associated throat cancer.

2025 NCI RNA Biology Symposium

Date: April 3-4, 2025
Location: Building 45, Natcher Auditorium

The mission of the NCI RNA Biology Initiative is to create an interdisciplinary environment that promotes the swift exchange of information and expertise regarding the structure, function, and biological significance of RNA. Our objective is to leverage our collective knowledge to advance the development of novel diagnostics and therapies. This biennial symposium, organized by the NCI RNA Biology Initiative, offers the opportunity to learn about new advances in multiple areas of RNA biology, to share research and to network with leading scientists, and to discuss the use and implications of these advances for clinical medicine.

Clinical trial researching CAR T-cell therapy for certain large B-cell lymphomas

A clinical trial led by Nirali N. Shah, M.D., M.H.Sc., Lasker Clinical Research Scholar in the Pediatric Oncology Branch, is studying the use of CAR T-cell therapy for relapsed or refractory large B-cell lymphoma (LBCL).

Clinical trial researching immunotherapy for cervical cancer

A clinical trial led by James L. Gulley, M.D., Ph.D., Co-Director of the Center for Immuno-Oncology, is researching combination immunotherapy for cervical cancer.

Clinical trial researching CAR T-cell therapy for acute myeloid leukemia

A clinical trial led by Nirali N. Shah, M.D., M.H.Sc., Lasker Clinical Research Scholar in the Pediatric Oncology Branch, is studying the use of CAR T-cell therapy for adult patients with relapsed or refractory acute myeloid leukemia (AML) after an allogeneic hematopoietic stem cell transplant.

Ruth Nussinov elected to the European Molecular Biology Organization

Ruth Nussinov, Ph.D., Senior Investigator in the Cancer Innovation Laboratory, was elected as a member of the European Molecular Biology Organization (EMBO). EMBO is an organization of more than 2,000 leading researchers that promotes excellence in the life sciences in Europe and beyond. Election as EMBO Member recognizes a scientist’s research excellence and outstanding achievements in their field.

Celebrating CCR Careers: R. Andrew Byrd, Ph.D.

32 years ago, R. Andrew Byrd, Ph.D., came to NCI Frederick to study the foundational biophysics of cancer. After an extensive career developing and utilizing nuclear magnetic resonance (NMR) spectroscopy methods to determine protein structures and mechanistic insight, he has announced his retirement.

Photomicrograph of a diffuse large B-cell lymphoma (DLBCL)

Technique targeting cell marker boosts treatment options for B-cell lymphomas

Researchers uncovered the mechanisms behind a drug treatment for diffuse large B-cell lymphoma (DLBCL). The findings help clarify why certain patients respond well to the treatment, while others do not.

Breadcrumb